Mohs Micrographic Surgery and Surgical Excision for Nonmelanoma Skin Cancer Treatment in the Medicare Population
Open Access
- 1 April 2012
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 148 (4), 473-477
- https://doi.org/10.1001/archdermatol.2011.2456
Abstract
More than 3 million nonmelanoma skin cancers (NMSCs) are diagnosed annually in the United States; 1 in 5 Americans will develop skin cancer during their lifetime.1,2 The NMSC treatment options include electrodessication and curettage, cryosurgery, photodynamic therapy, laser therapy, radiation, medical therapy, surgical excision, and Mohs micrographic surgery (MMS).3 Surgical excision is effective for most primary basal cell carcinomas, but cure rates are higher with MMS in patients with recurrent, infiltrative, and high-risk anatomical site (face) cancers; MMS examines 100% of the surgical margin, which ensures definitive tumor removal and minimal loss of surrounding normal tissue.3,4Keywords
This publication has 14 references indexed in Scilit:
- Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006Archives of Dermatology, 2010
- Mohs Versus Traditional Surgical Excision for Facial and Auricular Nonmelanoma Skin Cancer: An Analysis of Cost-EffectivenessDermatologic Surgery, 2009
- Mohs Micrographic Surgery for the Management of Nonmelanoma Skin CancersFacial Plastic Surgery Clinics of North America, 2009
- A relative value unit–based cost comparison of treatment modalities for nonmelanoma skin cancer: Effect of the loss of the Mohs multiple surgery reduction exemptionJournal of the American Academy of Dermatology, 2009
- Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-upThe Lancet Oncology, 2008
- Contemporary Mohs surgery applicationsCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2008
- Mohs Micrographic Surgery in the Treatment of Rare Aggressive Cutaneous Tumors: The Geisinger ExperienceDermatologic Surgery, 2007
- Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trialThe Lancet, 2004
- Variation in Care for Nonmelanoma Skin Cancer in a Private Practice and a Veterans Affairs ClinicMedical Care, 2004
- Guidelines of care for Mohs micrographic surgeryJournal of the American Academy of Dermatology, 1995